Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$22.18 -3.25 (-12.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) EBT (2010 - 2026)

Acadia Pharmaceuticals (ACAD) posted EBT of $46.5 million for Q2 2026, up 1062.5% on a QoQ basis from $4.0 million in Q1 2026, and up 15.64% year-over-year from $40.2 million in Q2 2025.

Analysis

Acadia Pharmaceuticals (ACAD) EBT (2010 - 2026) Analysis & Trends

Acadia Pharmaceuticals has reported EBT for 17 years, with the latest figure at $46.5 million in Q2 2026.

  • On a quarterly basis, EBT rose 15.64% year-over-year to $46.5 million in Q2 2026; TTM through Jun 2026 was $121.4 million, a 54.68% decrease from a year earlier, with the FY2025 full-year figure at $138.9 million, down 46.18% from the prior year.
  • EBT was $46.5 million for Q2 2026 at Acadia Pharmaceuticals, up from $4.0 million in the prior quarter.
  • The five-year high for EBT was $161.1 million in Q4 2024, with the low at -$112.6 million in Q1 2022.
  • Average EBT over 5 years is $10.2 million, with a median of $23.7 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: EBT plunged 97.4% in 2023, then jumped 486.47% in 2024.
  • Over 5 years, EBT stood at -$40.8 million in 2022, then surged by 197.21% to $39.7 million in 2023, then jumped by 305.7% to $161.1 million in 2024, then slumped by 83.67% to $26.3 million in 2025, then soared by 76.78% to $46.5 million in 2026.
  • The last three EBT figures came in at $46.5 million (Q2 2026), $4.0 million (Q1 2026), and $26.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 6.75 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 4.28 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -683.00 Mn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 4.27 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 2.80 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 2.77 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -10.25 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -653.00 Mn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 1.39 Bn
10 Acadia Pharmaceuticals 4.38 Bn 3.42 Bn 279.64 Mn 46.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.50 Mn
Mar 31, 2026 4.00 Mn
Dec 31, 2025 26.30 Mn
Sep 30, 2025 44.60 Mn
Jun 30, 2025 40.21 Mn
Mar 31, 2025 27.80 Mn
Dec 31, 2024 161.08 Mn
Sep 30, 2024 38.81 Mn
Jun 30, 2024 37.20 Mn
Mar 31, 2024 21.00 Mn
Dec 31, 2023 39.70 Mn
Sep 30, 2023 -52.14 Mn
Jun 30, 2023 6.34 Mn
Mar 31, 2023 -44.94 Mn
Dec 31, 2022 -40.84 Mn
Sep 30, 2022 -26.42 Mn
Jun 30, 2022 -33.60 Mn
Mar 31, 2022 -112.60 Mn
Dec 31, 2021 -42.91 Mn
Sep 30, 2021 -14.79 Mn
API Access

Acadia Pharmaceuticals EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=ACAD&period=max&api_key=YOUR_API_KEY